PURPOSE To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion. METHODS This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Peg...

AIM To evaluate factors influencing change in visual acuity (VA) after intravitreal injection of triamcinolone acetonide as treatment of exudative age related macular degeneration (AMD). METHODS This prospective, interventional, comparative non-randomised clinical case series study included 94 patients (99 eyes) showing progressive exudative AMD with occult (n = 61 eyes), minimally classic (n...

A 47 year old male patient visited our hospital with the chief complaint of deterioration of the visual acuity in the left eye. The fundus examination revealed thick hard exudates, multiple aneurysms and telangiectasias of the retinal vessels in the posterior pole. Fluorescein angiography demonstrated massive leakage over an area of the aneurysms. Optical coherence tomography (Stratus OCT; Zeis...

OBJECTIVE To evaluate the early effects of triamcinolone acetonide as monotherapy or as an adjuvant to ocular verteporfin photodynamic therapy (PDT) on angiogenesis in human choroidal neovascularization (CNV) secondary to age-related macular degeneration. METHODS Retrospective review of an interventional series of 55 patients who underwent CNV extraction. Eleven patients were treated with int...

purpose: to assess the effectiveness of intravitreal injection of triamcinolone acetonide on macular edema associated with branch retinal vein occlusion (brvo). design: a prospective noncomparative interventional case series. patients & methods: fourteen eyes of 14 patients with macular edema associated with brvo were enrolled. in all patients after thorough ophthalmic examination, 4 mg triamci...

c2010 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Table 1. Comparison of patient demographics and ...

Diabetic macular edema treatments have changed in recent years after the introduction of intravitreal injections of anti-vascular endothelial growth factor (VEGF) (ranibizumab, bevacizumab, pegaptanib and the most-recent introduction of aflibercept), corticoids (triamcinolone or dexamethasone), and the sustained delivery fluocinolone acetonide vitreous inserts. All these new drugs are becoming ...